Individuals with hearing disabilities often have issues with healthcare access due to communication gaps between them and medical staff. At the recent Beyond Dispensing: Malaysian Medical Sign Language 2019 workshop jointly organized by the Malaysian Community Pharmacy Business Forum (MyCPBF), the Malaysian Sign Language and Deaf Studies Association (MyBIM), The Light and the Malaysian Federation for the Deaf (MFD), a group of healthcare professionals took some time off to learn how to bridge the gaps.
At the recent 2nd Bayer Pharmacist Congress in July, a forum was held to discuss the topic of "Advancing the Role of Pharmacists in Primary Care". MPS and MCPG leaders shared their opinions on future directions of the profession and steps to take towards them.
Dr Andrew Ong, a consultant at the Department of Gastroenterology & Hepatology, Singapore General Hospital, explains to Roshini Claire Anthony the challenges in diagnosing and treating irritable bowel syndrome (IBS).
Assoc Prof Philip Eng, senior consultant respiratory physician at Mt Elizabeth Hospital in Singapore, shares his insights with Pearl Toh on diagnosing and managing pneumonia in the primary care setting.
In mid-March 2019, news of the Sungai Kim Kim chemical pollution disaster and its impact on thousands of Johor residents caught national attention. As healthcare services rushed in to provide medical aid, a temporary command centre was set up at Pasir Gudang Indoor Stadium to centralize efforts. MIMS Pharmacist spoke to three pharmacists about their experiences as volunteers there.
Dr Michael Lim, a senior consultant at the Paediatric Pulmonary and Sleep Division, National University Hospital, Singapore, speaks to Roshini Claire Anthony on the rare disease that is cystic fibrosis.
The eighth most common cancer among women in Singapore, the incidence of thyroid cancer has increased exponentially in the past decades. Fortunately, the most common types of thyroid cancer carry an excellent prognosis and are rarely the cause of mortality if detected early and treated.
Non-alcoholic fatty liver disease (NAFLD) – a clinicopathological spectrum comprising hepatic steatosis or non-alcoholic fatty liver (NAFL) and non-alcoholic steatohepatitis (NASH) – is the hepatic manifestation of metabolic syndrome recognized as a leading cause of liver morbidity and mortality. Dr Loo Wai Mun, Consultant at the Division of Gastroenterology and Hepatology, National University Hospital, Singapore, speaks with Audrey Abella to discuss how NAFLD can be best managed in primary care.
Supplementation with omega-3 fatty acids in combination with rosuvastatin may yield significant reductions in triglycerides and nonhigh-density lipoprotein (HDL) cholesterol as compared with rosuvastatin monotherapy, according to data from the ROMANTIC (rosuvastatin-omacor in residual hypertriglyceridemia) trial.
Early treatment with a triple antiviral combination of lopinavir-ritonavir, ribavirin, and interferon beta-1b significantly shortens the duration of virus shedding and reduces symptoms in patients with mild-to-moderate COVID-19 compared with lopinavir-ritonavir only, according to a recent study.
With recent recalls of losartan-containing products contaminated by potentially carcinogenic nitrosamines, MIMS speaks to the Malaysian National Pharmaceutical Regulatory Agency (NPRA) for more details.